Patent details

EP3409274 Title: DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

Basic Information

Publication number:
EP3409274
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP181793019
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
French Title of Invention:
RÉGIME POSOLOGIQUE POUR UN AGONISTE DU RÉCEPTEUR S1P
German Title of Invention:
DOSIERSCHEMA FÜR EINEN S1P-REZEPTOR-AGONISTEN
SPC Number:
LUC00183

Dates

Filing date:
21/12/2009
Grant date:
20/11/2019
EP Publication Date:
05/12/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/11/2019
EP B1 Publication Date:
20/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/12/2029
Renunciation date:
Revocation date:
27/11/2024
Annulment date:

Owner

From:
13/11/2019
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/11/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Schmouder, Robert
Address:
United States (US)

2

Name:
Dumortier, Thomas
Address:
Switzerland (CH)

3

Name:
Looby, Michael
Address:
Switzerland (CH)

4

Name:
David, Olivier
Address:
Switzerland (CH)

Priority

1

Priority Number:
139672 P
Priority Date:
22/12/2008
Priority Country:
United States (US)

2

Priority Number:
218530 P
Priority Date:
19/06/2009
Priority Country:
United States (US)

3

Priority Number:
246715 P
Priority Date:
29/09/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/135; A61K 31/137; A61K 31/138; A61K 31/661; A61P 37/00; A61P 37/06;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2025/02
Publication date:
06/02/2025
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201947
Publication date:
20/11/2019
Description:
Grant (B1)

2

Issue number:
202039
Publication date:
23/09/2020
Description:
Opposition procedure started

3

Issue number:
202502
Publication date:
08/01/2025
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
25/11/2019 Power Of Attorney 1
25/11/2019 Outgoing Correspondence 1